Edition:
India

Rocket Pharmaceuticals Inc (RCKT.OQ)

RCKT.OQ on NASDAQ Stock Exchange Global Market

17.25USD
23 Apr 2018
Change (% chg)

$-0.02 (-0.12%)
Prev Close
$17.27
Open
$17.25
Day's High
$17.25
Day's Low
$17.25
Volume
539
Avg. Vol
86,828
52-wk High
$20.60
52-wk Low
$3.40

Chart for

About

Rocket Pharmaceuticals, Inc., formerly Inotek Pharmaceuticals Corporation, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. Its lead product candidate, trabodenoson, is a selective adenosine mimetic... (more)

Overall

Beta: --
Market Cap(Mil.): $70.77
Shares Outstanding(Mil.): 27.01
Dividend: --
Yield (%): --

Financials

Rocket-control glitch delays launch of NASA's planet-hunting satellite

CAPE CANAVERAL, Fla. An 11th-hour technical glitch prompted SpaceX to postpone its planned launch on Monday of a new NASA space telescope designed to detect worlds beyond our solar system, delaying for at least 48 hours a quest to expand astronomers' known inventory of so-called exoplanets.

17 Apr 2018

Rocket-control glitch delays launch of NASA's planet-hunting satellite

CAPE CANAVERAL, Fla. An 11th-hour technical glitch prompted SpaceX to postpone its planned launch on Monday of a new NASA space telescope designed to detect worlds beyond our solar system, delaying for at least 48 hours a quest to expand astronomers' known inventory of so-called exoplanets.

17 Apr 2018

BRIEF-Rocket Pharmaceuticals Reports Full-Year 2017 Results

* ROCKET PHARMACEUTICALS REPORTS FULL YEAR 2017 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

06 Mar 2018

BRIEF-Rocket Pharmaceuticals Prices Public Offering Of Common Stock

* ROCKET PHARMACEUTICALS PRICES PUBLIC OFFERING OF COMMON STOCK

24 Jan 2018

BRIEF-Rocket Pharmaceuticals Announces Proposed Public Offering Of Common Stock

* ROCKET PHARMACEUTICALS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

24 Jan 2018

BRIEF-Tang Capital Partners Reports 8.1 Pct Passive Stake In Rocket Pharmaceuticals - SEC Filing

* TANG CAPITAL PARTNERS REPORTS 8.1 PCT PASSIVE STAKE IN ROCKET PHARMACEUTICALS INC AS OF JAN 4 - SEC FILING Source text: (http://bit.ly/2ra05Is) Further company coverage:

17 Jan 2018

Rocket Internet CEO says ready to pounce with cash pile

BERLIN Germany's Rocket Internet needs to hold on to its mountain of cash so it can compete with rivals from the United States and China and pounce when investment opportunities arise, the chief executive said in an interview.

11 Jan 2018

Interview: Rocket Internet CEO says ready to pounce with cash pile

BERLIN Germany's Rocket Internet needs to hold on to its mountain of cash so it can compete with rivals from the United States and China and pounce when investment opportunities arise, the chief executive said in an interview.

11 Jan 2018

Earnings vs. Estimates